Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on asymmetric catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN114644614B reveals a novel 3-step route to L-nicotine with >99.9% ee. Discover cost-effective manufacturing and supply chain advantages for pharma intermediates.
Patent CN1566084A reveals novel water-soluble diamines enabling green asymmetric hydrogenation. Discover cost-effective API intermediate manufacturing solutions.
Patent CN102675168A details a high-ee iridium-catalyzed allylation method for chiral thioethers, offering superior regioselectivity and mild conditions for API intermediates.
Patent CN101346352B reveals efficient Rh-catalyzed asymmetric reduction for Mitiglinide. Offers high optical purity and industrial scalability for diabetes drug intermediates.
Patent CN101346352B reveals a novel rhodium-catalyzed asymmetric reduction for Mitiglinide intermediates, offering superior optical purity and industrial scalability for pharmaceutical manufacturers.
Patent CN104892575A details asymmetric oxidation for high-purity PPI intermediates. This method offers significant cost reduction and supply chain reliability for global pharmaceutical manufacturers.
Novel asymmetric process for Sitagliptin ensures high yield and purity. Reliable pharmaceutical intermediates supplier offering cost reduction in API manufacturing and scalable solutions.
Patent CN101537373B discloses novel binaphthyl spirocyclic phosphonium salts achieving 98% ee. Ideal for reliable pharmaceutical intermediate supplier seeking cost-effective asymmetric synthesis.
Patent CN115806504A reveals a novel chiral copper MOF catalyst enabling 99.7% ee for indoxacarb intermediates, offering significant cost reduction and supply chain reliability.
Patent CN103373948A details a high-yield 6-step asymmetric synthesis of (-)-Kainic Acid using Rh-catalysis, offering a reliable alternative to natural extraction for neuroscience research.
Patent CN112624901B details a novel refining method for chiral alcohols using polymer-supported catalysts and specific ether solvents, ensuring >99% purity for API manufacturing.
Patent CN101851195B details a novel 11-step quinoline synthesis for camptothecin. Discover cost-effective routes and high-purity intermediates for API manufacturing.
Patent CN105777740B reveals a streamlined four-step route for isavuconazole, offering substantial cost reduction and supply chain reliability for global pharmaceutical manufacturing partners.
Patent CN110668976A reveals a novel Ir-catalyzed asymmetric synthesis for (R)-Rivastigmine intermediates, offering superior yield and purity for reliable pharmaceutical supply chains.
Patent CN109111380B introduces a transition-metal-free method for synthesizing chiral amines via hydrogen borrowing, offering cost reduction in API manufacturing and high stereoselectivity.
Novel side-arm ferrocene ligands enable efficient asymmetric cyclopropanation for pyrethroid production with high yield and selectivity.
Advanced asymmetric copper complex technology for high-purity cyclopropane carboxylates. Enables cost reduction in pharmaceutical intermediates manufacturing and agrochemical production.
Patent CN101516898B details a novel asymmetric Strecker reaction for L-AMPB production, offering significant cost reduction in herbicide manufacturing and scalable supply chain solutions.
Patent CN100361971C reveals tunable L-proline catalysts for asymmetric aldol reactions, offering metal-free synthesis routes and significant cost reduction in pharmaceutical intermediates manufacturing.
Novel asymmetric synthesis of chiral dihydrofurans via squaric acid catalysis. High enantioselectivity and mild conditions for API manufacturing.